| 51 |
11504769 | Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance. | 2001 Aug 15 |
1 |
| 52 |
10815934 | Oral efficacy and bioavailability of a novel taxane. | 2000 May |
2 |
| 53 |
11052631 | Multiple factors other than p53 influence colon cancer sensitivity to paclitaxel. | 2000 |
1 |
| 54 |
11062698 | The human multidrug resistance gene (MDR-1): immunocytochemical detection of its expression in oral SCC. | 2000 Sep-Oct |
1 |
| 55 |
11093797 | Reversal of P-glycoprotein and multidrug-resistance protein-mediated drug resistance in KB cells by 5-O-benzoylated taxinine K. | 2000 Dec |
2 |
| 56 |
11104578 | Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitors. | 2000 Dec |
5 |
| 57 |
9458331 | Effects of tubulin-inhibiting agents in human lung and breast cancer cell lines with different multidrug resistance phenotypes. | 1998 Jan-Feb |
1 |
| 58 |
10021886 | [The causes of treatment ineffectiveness in acute myelogenous leukemia--the role of blast resistance to cytotoxic drugs]. | 1998 |
1 |
| 59 |
21544450 | P-glycoprotein-associated resistance to taxol and taxotere and its reversal by dexniguldipine-HCl, dexverapamil-HCl, or cyclosporin A. | 1996 May |
1 |